SNP-SNP interaction | SNP Genotypes | Cases n | Controls n | OR†| 95% CI†| |
---|---|---|---|---|---|---|
 | XPD | IL10 |  |  |  |  |
XPD-[Lys751Gln] and IL10-[G(-1082)A] | AA | AA | 40 | 57 | 1.0 | - |
 | AC | AA | 45 | 39 | 1.7 | [0.9–2.7] |
 | CC | AA | 21 | 8 | 3.7 | [1.6–9.7] |
 | AA | AG | 74 | 89 | 1.2 | [0.8–1.9] |
 | AC | AG | 99 | 71 | 1.9 | [1.3–3.1] |
 | CC | AG | 22 | 22 | 1.4 | [0.8–3.1] |
 | AA | GG | 41 | 26 | 2.2 | [1.3–3.9] |
 | AC | GG | 42 | 50 | 1.2 | [0.7–2.4] |
 | CC | GG | 14 | 10 | 2.2 | [0.8–5.5] |
 | BARD1 | XPD |  |  |  |  |
BARD1-[Pro24Ser] and XPD-[Lys751Gln] | CC | AA | 66 | 60 | 1.0 | - |
 | CT | AA | 68 | 90 | 0.7 | [0.4–1.1] |
 | TT | AA | 21 | 22 | 0.9 | [0.4–1.8] |
 | CC | AC | 82 | 67 | 1.1 | [0.7–1.8] |
 | CT | AC | 89 | 69 | 1.2 | [0.7–1.9] |
 | TT | AC | 15 | 24 | 0.6 | [0.3–1.2] |
 | CC | CC | 23 | 13 | 1.6 | [0.7–3.4] |
 | CT | CC | 27 | 26 | 1.0 | [0.5–1.9] |
 | TT | CC | 7 | 1 | 7.4 | [1.3–12.4] |
 | COMT | CCND1 |  |  |  |  |
COMT-[Met108/158Val] and CCND1-[Pro241Pro] | AA | GG | 21 | 40 | 1.0 | - |
 | AG | GG | 57 | 53 | 1.9 | [1.3–4.6] |
 | GG | GG | 25 | 21 | 2.4 | [1.0–4.9] |
 | AA | AG | 48 | 36 | 2.6 | [1.3–4.5] |
 | AG | AG | 110 | 92 | 2.3 | [1.3–4.5] |
 | GG | AG | 38 | 45 | 1.6 | [1.0–3.2] |
 | AA | AA | 22 | 29 | 1.4 | [0.7–3.3] |
 | AG | AA | 43 | 37 | 2.2 | [1.1–4.3] |
 | GG | AA | 34 | 19 | 3.3 | [1.9–7.2] |
 | GSTP1 | COMT |  |  |  |  |
GSTP1-[Ile105Val] and COMT-[Met108/158Val] | AA | AA | 30 | 49 | 1.0 | - |
 | AG | AA | 46 | 48 | 1.5 | [0.9–2.8] |
 | GG | AA | 15 | 8 | 3.4 | [1.1–11.4] |
 | AA | AG | 95 | 92 | 1.7 | [1.0–2.6] |
 | AG | AG | 91 | 69 | 2.2 | [1.4–3.6] |
 | GG | AG | 24 | 21 | 1.8 | [0.9–4.8] |
 | AA | GG | 54 | 36 | 2.6 | [1.4–4.2] |
 | AG | GG | 36 | 41 | 1.5 | [0.9–2.7] |
 | GG | GG | 7 | 8 | 1.6 | [0.5–4.2] |